Results 11 to 20 of about 183,492 (354)
NON-ALCOHOLIC FATTY LIVER DISEASE [PDF]
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2015 Paralelno s porastom prevalencije pretilosti i metaboličkog sindroma nealkoholna masna bolest jetre - NAFLD (engl. Non-Alcoholic Fatty Liver Disease) sve se više prepoznaje kao najčešća bolest jetre odraslih i djece.
ALEKSANDAR LJUBOTINA +4 more
core +8 more sources
Statins and non-alcoholic fatty liver disease [PDF]
Liver International, 2019 Dear Editor, In April 9 issue, van den Berg et al1 report interesting results on the indication for lipid‐lowering treatment in a large cohort with suspected non‐alcoholic fatty liver disease (NAFLD) within the population‐based Lifelines Cohort Study.
Angelico, F +3 more
core +3 more sources
Non alcoholic fatty liver disease
Annals of Hepatology, 2009 A 45 year old man with known hypertension, type 2 diabetes mellitus, and central obesity presents with fatigue and mild discomfort in the abdominal right upper quadrant. Repeated blood tests show a persistent alanine aminotransferase concentration of 100 IU/l (reference range 10-50) and a γ glutamyl transferase concentration of 80 IU/l (range 10-50 ...
Nahum Méndez-Sánchez
doaj +5 more sources
Non-alcoholic fatty liver disease [PDF]
BMC Medicine, 2017 Non-alcoholic fatty liver disease has emerged a major challenge because of it prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies. As the burden of hepatitis C abates over the next decade, non-alcoholic fatty liver disease will become the major form of chronic liver disease in adults and children and could become
Brent A. Neuschwander-Tetri
core +6 more sources
Non-Alcoholic Fatty Liver Disease [PDF]
Vnitřní lékařství, 2019 Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of a metabolic syndrome, is a leading cause of chronic liver disease worldwide with prevalence 17-46 % in adult population. NAFLD is associated with type 2 diabetes, obesity and genetic factors and includes a spectrum of potentially progressive liver disease that comprises of simple ...
Farrell, Geoffrey +3 more
openaire +5 more sources
Non-Alcoholic Fatty Liver Disease in Children [PDF]
Medicina, 2021 Background and Objectives: The prevalence of pediatric non-alcoholic fatty liver disease is increasing. A lot of new data are published regularly. Materials and Methods: Original clinical studies, review articles, and guidelines in children were searched for and the most relevant included in this review.
Jernej Brecelj, Rok Orel
openaire +4 more sources
Non-alcoholic fatty liver disease [PDF]
Clinical Medicine, 2020 Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. NAFLD is defined by excess fat in the liver and has a multidirectional relationship with metabolic syndrome. The prevalence of NAFLD has risen rapidly in recent years in line with the obesity epidemic and associated increases in type 2 diabetes ...
Wenhao, Li, William, Alazawi
openaire +2 more sources
Non-alcoholic fatty liver disease [PDF]
Clinical Medicine, 2018 Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of about 25%. Incidence is increasing with rising levels of obesity, type 2 diabetes and the metabolic syndrome, and NAFLD is predicted to become the leading cause of cirrhosis requiring liver transplantation in the next decade.
Maurice, J, Manousou, P
openaire +4 more sources
Frontiers in Medicine, 2020 Non-alcoholic fatty liver disease represents a continuum of excessive hepatic steatosis, inflammation and fibrosis. It is a growing epidemic in the United States of America and worldwide.
Muhammad Amir +4 more
doaj +1 more source
BMC Gastroenterology, 2021 Background Causes of non-alcoholic fatty liver disease and its progression include visceral fat accumulation and loss of muscle mass; however, which of the two phenomena is more critical is unclear.
Teruki Miyake +18 more
doaj +1 more source